Application 211722
- Type
- ANDA
- Sponsor
- TARO PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | SPRAY;TOPICAL | EQ 0.05% BASE/SPRAY | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51672-1390 | Betamethasone dipropionate | Betamethasone dipropionate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64420 | ORIG | 2020-08-26 |